Results 291 to 300 of about 157,656 (310)

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

Lancet, The, 2018
Craig M Mcdonald, Paula R Clemens, Heather Gordish-Dressman   +2 more
exaly  

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Lancet, The, 2011
Sebahattin Cirak, V Arechavala-Gomeza, Michela Guglieri   +2 more
exaly  

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial

Lancet, The, 2015
Thomas Voit, Janbernd Kirschner, Richard S Finkel   +2 more
exaly  

Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy

Lancet, The, 1994
Sylvie Chevret
exaly  

Ultrarare Muscular Dystrophy Mimics Facioscapulohumeral Muscular Dystrophy

Pediatric Neurology
Bret J. Gardner, Meeta Cardon
openaire   +2 more sources

Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study

Lancet, The, 1999
exaly  

Prevalence and incidence of Becker muscular dystrophy

Lancet, The, 1991
exaly  

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2017
Craig M Mcdonald, Craig Campbell, Linda P Lowes   +2 more
exaly  

Limitation of eye movement in merosin-deficient congenital muscular dystrophy

Lancet, The, 1999
exaly  

Location of facioscapulohumeral muscular dystrophy gene on chromosome 4

Lancet, The, 1990
exaly